June 23, 2014 BIOVECTRA Announces Acquisition of Former Sunovion (Sepracor) Facility BIOVECTRA, a specialized cGMP manufacturer, and developer of pharmaceutical ingredients has announced today that it has agreed to purchase the previous Sepracor Canada Limited facility at Windsor, Nova Scotia, for an undisclosed sum. View Article […]
June 14, 2014 BIOVECTRA Spending $3.8 Million on Expansion An Island company that has been in business for more than 40 years is growing as BIOVECTRA invests $3.8 million to expand one of its facilities in Charlottetown. View Article […]
June 11, 2014 BIOVECTRA Starts Construction to Expand Charlottetown Facility BIOVECTRA, a specialized manufacturer and developer of pharmaceutical ingredients for the global marketplace, has commenced the expansion of one of its Prince Edward Island facilities, located at 11 Aviation Avenue, adjacent to the Charlottetown airport. View Article […]
With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.